Literature DB >> 28063014

Roles of IκB kinase ε in the innate immune defense and beyond.

Junjie Zhang1, Mao Tian2, Zanxian Xia3, Pinghui Feng2.   

Abstract

IκB kinase ε (IKKε) is a non-canonical IκB kinase that is extensively studied in the context of innate immune response. Recently, significant progress has been made in understanding the role of IKKε in interferon (IFN) signaling. In addition to its roles in innate immunity, recent studies also demonstrate that IKKε is a key regulator of the adaptive immune response. Specifically, IKKε functions as a negative feedback kinase to curtail CD8 T cell response, implying that it can be a potential therapeutic target to boost antiviral and antitumor T cell immunity. In this review, we highlight the roles of IKKε in regulating IFN signaling and T cell immunity, and discuss a few imminent questions that remain to be answered.

Entities:  

Keywords:  IFN signaling; IκB kinase ε (IKKε); T cell immunity; antiviral immune response

Mesh:

Substances:

Year:  2016        PMID: 28063014      PMCID: PMC8193418          DOI: 10.1007/s12250-016-3898-y

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  56 in total

1.  Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases.

Authors:  Tao Wang; Michael A Block; Scott Cowen; Audrey M Davies; Erik Devereaux; Lakshmaiah Gingipalli; Jeffrey Johannes; Nicholas A Larsen; Qibin Su; Julie A Tucker; David Whitston; Jiaquan Wu; Hai-Jun Zhang; Michael Zinda; Claudio Chuaqui
Journal:  Bioorg Med Chem Lett       Date:  2012-01-14       Impact factor: 2.823

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription.

Authors:  M Bonnard; C Mirtsos; S Suzuki; K Graham; J Huang; M Ng; A Itié; A Wakeham; A Shahinian; W J Henzel; A J Elia; W Shillinglaw; T W Mak; Z Cao; W C Yeh
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

4.  NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells.

Authors:  Ehrin N Johnson; You Mie Lee; Tara L Sander; Elena Rabkin; Frederick J Schoen; Sunjay Kaushal; Joyce Bischoff
Journal:  J Biol Chem       Date:  2002-11-09       Impact factor: 5.157

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response.

Authors:  Junjie Zhang; Hao Feng; Jun Zhao; Emily R Feldman; Si-Yi Chen; Weiming Yuan; Canhua Huang; Omid Akbari; Scott A Tibbetts; Pinghui Feng
Journal:  Cell Rep       Date:  2016-06-23       Impact factor: 9.423

7.  Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.

Authors:  Jessica E Hutti; Rhine R Shen; Derek W Abbott; Alicia Y Zhou; Kam M Sprott; John M Asara; William C Hahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-05-14       Impact factor: 17.970

8.  IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFR.

Authors:  Sridevi Challa; Jian-Ping Guo; Xiaowen Ding; Cheng-Xiong Xu; Yajuan Li; Donghwa Kim; Matthew A Smith; Douglas W Cress; Domenico Coppola; Eric B Haura; Jin Q Cheng
Journal:  Cancer Res       Date:  2016-06-10       Impact factor: 12.701

9.  Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation.

Authors:  Kristopher Clark; Lorna Plater; Mark Peggie; Philip Cohen
Journal:  J Biol Chem       Date:  2009-03-22       Impact factor: 5.157

10.  Development of a high-throughput assay for identifying inhibitors of TBK1 and IKKε.

Authors:  Jessica E Hutti; Melissa A Porter; Adam W Cheely; Lewis C Cantley; Xiaodong Wang; Dmitri Kireev; Albert S Baldwin; William P Janzen
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more
  7 in total

1.  The E3 Ubiquitin Ligase TBK1 Mediates the Degradation of Multiple Picornavirus VP3 Proteins by Phosphorylation and Ubiquitination.

Authors:  Dan Li; Wenping Yang; Jingjing Ren; Yi Ru; Keshan Zhang; Shaozu Fu; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

Review 2.  Targeting IκappaB kinases for cancer therapy.

Authors:  Nikee Awasthee; Vipin Rai; Srinivas Chava; Palanisamy Nallasamy; Ajaikumar B Kunnumakkara; Anupam Bishayee; Subhash C Chauhan; Kishore B Challagundla; Subash C Gupta
Journal:  Semin Cancer Biol       Date:  2018-02-24       Impact factor: 15.707

3.  A Novel Molecular Mechanism of IKKε-Mediated Akt/mTOR Inhibition in the Cardiomyocyte Autophagy after Myocardial Infarction.

Authors:  Shuai He; Jian Shen; Liangpeng Li; Yueyue Xu; Yide Cao; Li Yin; Zhonghao Tao; Zhibing Qiu; Wen Chen; Xin Chen
Journal:  Oxid Med Cell Longev       Date:  2020-07-16       Impact factor: 6.543

4.  Immune Tolerance vs. Immune Resistance: The Interaction Between Host and Pathogens in Infectious Diseases.

Authors:  Hafiz Ishfaq Ahmad; Abdul Jabbar; Nadia Mushtaq; Zainab Javed; Muhammad Umar Hayyat; Javaria Bashir; Iqra Naseeb; Zain Ul Abideen; Nisar Ahmad; Jinping Chen
Journal:  Front Vet Sci       Date:  2022-03-29

5.  I-κB kinase-ε deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-κB pathway.

Authors:  Yafeng Liu; Yueyue Xu; Yiwei Yao; Yide Cao; Ganyi Chen; Yuchen Cai; Wen Chen; Xin Chen; Zhibing Qiu
Journal:  Front Physiol       Date:  2022-08-04       Impact factor: 4.755

6.  Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε.

Authors:  Lok-Yin Roy Wong; Zi-Wei Ye; Pak-Yin Lui; Xuyang Zheng; Shuofeng Yuan; Lin Zhu; Sin-Yee Fung; Kit-San Yuen; Kam-Leung Siu; Man-Lung Yeung; Zongwei Cai; Patrick Chiu-Yat Woo; Kwok-Yung Yuen; Chi-Ping Chan; Dong-Yan Jin
Journal:  J Immunol       Date:  2020-08-03       Impact factor: 5.426

7.  Dynamic chromatin accessibility landscape changes following interleukin-1 stimulation.

Authors:  Matt J Barter; Kathleen Cheung; Julia Falk; Andreas C Panagiotopoulos; Caitlin Cosimini; Siobhan O'Brien; Karina Teja-Putri; Graham Neill; David J Deehan; David A Young
Journal:  Epigenetics       Date:  2020-08-02       Impact factor: 4.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.